Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity
Sentiment Mix
Expert Signals
CBS News - Top Stories
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity.
Supported by 1 story
Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity.
Supported by 1 story
The FDA has approved GLP-1 drugs for weight loss among kids 12 and older.
Supported by 1 story
Related Events
Teen climbs out of Disneyland attraction mid-ride, taken to hospital - KTLA
Uncategorized • 6/23/2026
Siblings become first brother-sister duo to win $75M Lotto Max jackpot with OLG
Uncategorized • 6/23/2026
Trump’s international approval ratings plummet, even among far-right groups - The Globe and Mail
Uncategorized • 6/23/2026
Drivers launch lawsuit against fuel stations over 'astronomical' petrol and diesel prices
Product Launch • 6/23/2026
Peptide alternative to antibiotics could combat antimicrobial resistance crisis - University of Alberta
Uncategorized • 6/23/2026